CD274 and neoplasm: Initial tumor biopsy assessment of PD-L1 abundance, TIL infiltration, and ECM status, combined with longitudinal assessment of changes in each factor during treatment, may have a unique potential to predict tumor phenotypes that respond to ICIs.